Holen Sie sich die Stockscreener-App
1.24
5.08%
0.06
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
AEMD Reaches Milestone in Australian Hemopurifier Trial | AEMD Stock News - GuruFocus
Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial | AEMD Stock News - GuruFocus
Cancer Trial Breakthrough: Aethlon's Hemopurifier Shows Promise in Treating Therapy-Resistant Tumors - Stock Titan
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier By Investing.com - Investing.com South Africa
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier - Investing.com Nigeria
Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream - GlobeNewswire Inc.
AEMD: Virtual Meeting With Management, Upcoming Presentation of Data in Long Covid - Yahoo Finance
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Drop in Short Interest - Defense World
Medical Tech NewsAethlon Medical (NASDAQ: AEMD) to Present New Pre-Clinical Data on Long COVID and Post-Acute Infection Syndromes - Investorideas.com
AEMD to Present on Long COVID at Keystone Symposium | AEMD Stock News - GuruFocus
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes | AEMD Stock News - GuruFocus
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes - Yahoo Finance
Potential Long COVID Treatment Breakthrough: Aethlon Medical's Device Shows Promise for 48M Patients - Stock Titan
AEMD Trading Halted Pending Important Announcement | AEMD Stock News - GuruFocus
Exosome Therapy Market May See a Big Move | Major Giants- Exiqon, Exosome Diagnostic, NanoSomix - openPR.com
aethlon medical announces reverse stock split effective june 6 By Investing.com - Investing.com South Africa
Aethlon Medical Approves Reverse Stock Split Plan - TipRanks
aethlon medical announces reverse stock split effective june 6 - Investing.com
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update - Defense World
Exosomes Market Projected to Reach USD 1,311.03 Million by - GlobeNewswire
Aethlon Adds to Board - Medical Product Outsourcing
FDA Grants Aethlon Compassionate Use Approval for its Hemopurifier to Help Fight Ebola - Medical Product Outsourcing
FDA OKs Aethlon to Export Hemopurifier to India - Medical Product Outsourcing
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtrati - GuruFocus
AEMD: Aethlon Medical Unveils Study on Innovative Blood Filtration System | AEMD Stock News - GuruFocus
Aethlon Medical Announces Publication of Preclinical Data Showin - GuruFocus
Revolutionary Blood Filtration Device Shows 98.5% Success Rate in Cancer and Alzheimer's Treatment Study - Stock Titan
Aethlon Medical Approves Key Stockholder Proposals - TipRanks
Comparing Paragon 28 (NYSE:FNA) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Decline in Short Interest - Defense World
AEMDAethlon Medical Latest Stock News & Market Updates - Stock Titan
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Exosomes Market Size, Top Share, and Industry Analysis Report by 2033 - Straits Research
Virtu Financial LLC Buys Shares of 94,173 Aethlon Medical, Inc. (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 46.7% in March - Defense World
Aethlon Medical at Emerging Growth Virtual Conference: Oncology Focus and Financial Strategy - Investing.com
Aethlon Medical (NASDAQ:AEMD) & Nephros (NASDAQ:NEPH) Head to Head Comparison - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com - Defense World
Aethlon Medical issues new warrants, modifies rights By Investing.com - Investing.com Australia
Aethlon Medical issues new warrants, modifies rights - Investing.com
Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Drops By 52.0% - Defense World
HC Wainwright Reiterates Buy Rating for Aethlon Medical (NASDAQ:AEMD) - The AM Reporter
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):